“…Pathogenesis of both IgAN and IgAVN is thought to occur through a multi-hit process [ 5 ]. This process includes the production of galactose-deficient IgA1 (Gd-IgA1) [ 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 ], generation of circulating IgG autoantibodies specific for Gd-IgA1 [ 29 , 30 , 31 , 32 , 33 , 34 ], formation of pathogenic Gd-IgA1-containing immune complexes [ 30 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 ], and the subsequent mesangial deposition of these immune complexes resulting in glomerular injury [ 34 , 44 ].…”